RTI Talking With Potential Acquirer, Seeking Clearance For Xenograft Implant
This article was originally published in The Gray Sheet
Executive Summary
Regeneration Technologies, Inc.'s compliance with FDA's Good Tissue Practice regulations may have piqued the interest of a potential acquirer or strategic partner with whom the biologics manufacturer apparently is in discussions